Evidence map›Paper›PMID 24711627›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2014

Time-varying processes involved in smoking lapse in a randomized trial of smoking cessation therapies.

Sara A Vasilenko, Megan E Piper, Stephanie T Lanza, Xiaoyu Liu, Jingyun Yang, Runze Li

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Time-Varying Mediation of Pharmacological Smoking Cessation Treatments on Smoking Lapse via Craving, Cessation Fatigue, and Negative Mood.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Trial
  5. Trial
  6. Very Low Nicotine Content Cigarettes Disrupt the Feedback Loop of Affective States and Smoking Behavior.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Trial
  7. Cigarette Nicotine Content as a Moderator of the Relationship Between Negative Affect and Smoking.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2017
    Trial
  8. Article
  9. Article
  10. Article
  11. In the Presence of Parents: Parental Heterosexism and Momentary Negative Affect and Substance Craving Among Sexual Minority Youth.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2023
    Article
  12. A time-varying model of the dynamics of smoking lapse.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. The Time-Varying Relations Between Risk Factors and Smoking Before and After a Quit Attempt.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sara A VasilenkoMethodology Center, Pennsylvania State University, University Park, PA;
Megan E Piper
Stephanie T Lanza
Xiaoyu Liu
Jingyun Yang
Runze Li
Pennsylvania State University · USUniversity of Wisconsin–Madison · US

Funding

THE REFINEMENT &APPLICATION OF MEDICAL DECISION MAKING IN PREVENTION SCIENCESP50DA010075 · NIDA · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI LANZA, STEPHANIE T · 1996 to 2014
$24.5M
Testing Relapse Recovery Intervention ComponentsP01CA180945 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI COOK, JESSICA MEGAN · 2014 to 2023
$23.0M
ZOSUQUIDAR TRIHYDROCHLORIDE IN NEWLY DIAGNOSED AMLM01RR003186 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI MATLOUB, YOUSIF H · 1986 to 2007
$19.3M
Enhancing the Effectiveness of Varenicline Based Smoking Cessation TreatmentR01HL109031 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI BAKER, TIMOTHY B, STEIN, JAMES H · 2011 to 2020
$17.5M
Transforming The Treatment of Tobacco Use in Health Care: Seizing The Potential of the Electronic Health Record to Deliver Comprehensive Chronic Care Treatment for SmokingR35CA197573 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI MICHAEL C FIORE · 2015 to 2026
$10.7M
PREVENTION AND METHODOLOGY TRAINING (PAMT)T32DA017629 · NIDA · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI Eric D Claus, Rina D Eiden · 2005 to 2026
$9.5M
RELAPSE: LINKING SCIENCE AND PRACTICEP50CA084724 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI FIORE, MICHAEL C · 1999 to 2003
$8.9M
New Statistical Models for Intensive Longitudinal DataR21DA024260 · NIDA · PENNSYLVANIA STATE UNIVERSITY, THE · PI DIERKER, LISA C, LI, RUNZE · 2007 to 2010
$1.2M
Advancing Tobacco Research by Integrating Systems Science and Mixture ModelsR01CA168676 · NCI · PENNSYLVANIA STATE UNIVERSITY, THE · PI LANZA, STEPHANIE T · 2012 to 2014
$498k
NCI NIH HHS P01 CA180945NCI NIH HHS P50-CA84724NCI NIH HHS R01 CA168676NCI NIH HHS R01-CA168676NCRR NIH HHS M01-RR03186NHLBI NIH HHS R01 HL109031NIDA NIH HHS P50 DA010075NIDA NIH HHS P50-DA010075-16NIDA NIH HHS P50-DA0197NIDA NIH HHS R21-DA024260NIDA NIH HHS T32-DA017629
6 · The paper itself

Abstract

introductionResearchers have increasingly begun to gather ecological momentary assessment (EMA) data on smoking, but new statistical methods are necessary to fully unlock information from such data. In this paper, we use a new technique, the logistic time-varying effect model (logistic TVEM), to examine the odds of smoking in the 2 weeks after a quit attempt.

methodsData are from a subsample of participants from a randomized, placebo-controlled trial of smoking cessation pharmacotherapies who achieved initial abstinence (N = 1,106, 58% female). Participants completed up to 4 EMA assessments per day during the 2 weeks after their quit day. Predictors include baseline nicotine dependence, EMA measures of craving and negative affect, and whether an individual was assigned to a placebo, monotherapy, or combination therapy condition. Time-varying effects of these predictors were estimated using logistic TVEM.

resultsCravings were a significant predictor of smoking throughout the entire 2 weeks postquit, whereas the effect of baseline dependence became nonsignificant by the second week, and the effect of negative affect increased over time. Individuals in the monotherapy and combination therapy conditions had decreased odds of smoking compared with placebo in the first week postquit, but these differences were nonsignificant in the second week.

conclusionsFindings suggest that pharmacotherapies are more effective compared with placebo earlier in a quit attempt, when the effect of baseline nicotine dependence on smoking is stronger, whereas the effect of craving and negative affect increased over time. Future cessation therapies may be more successful by providing additional support in the second week after quit attempt.

Indexed as

CravingAdultCombined Modality TherapyFemaleHumansLogistic ModelsMaleMiddle AgedPsychopharmacologySmokingSmoking CessationTime FactorsTobacco Use Disorder

Identifiers

PMID24711627
PMCPMC3977637
OpenAlexW2144197733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.